NCT03098589 2025-03-30Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)CelgeneCompleted1,149 enrolled
NCT05852002 2024-01-17A Clinical Study of Pain and Discomfort Associated With Advanced Lung CancerNakhia Impex LLCPhase NA Completed10 enrolled
NCT04803305 2024-01-12Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and AnorexiaPfizerPhase 1 Completed18 enrolled 14 charts
NCT04299048 2023-12-14Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.PfizerPhase 1 Completed11 enrolled 13 charts
NCT02921828 2022-07-05A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mgCelgeneCompleted1,149 enrolled
NCT00866970 2020-07-09Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and CachexiaCSL BehringPhase 2 Completed124 enrolled
NCT01160380 2014-11-06A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple MyelomaOncotherapeuticsPhase 3 Completed50 enrolled 14 charts
NCT00047476 2005-06-24D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer PatientsCelgenePhase 2 Completed160 enrolled